ResMed

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023

Retrieved on: 
星期四, 一月 26, 2023
Australian Securities Exchange, COVID-19, CHESS, Home medical equipment, NYSE, Acquisition, CDI, Webcast, Sleep, CDIS, Software as a service, Growth, ResMed, Cryptocurrency, Retail, Health insurance

SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2022.

Key Points: 
  • SG&A expenses improved to 20.5 percent of revenue in the quarter, compared with 20.7 percent in the same period of the prior year.
  • The dividend will have a record date of February 9, 2023, payable on March 16, 2023.
  • ResMed has received a waiver from the ASX’s settlement operating rules, which will allow ResMed to defer processing conversions between its common stock and CDI registers from February 8, 2023, through February 9, 2023, inclusive.
  • ResMed will discuss its second-quarter fiscal year 2023 results on its webcast at 1:30 p.m. U.S. Pacific Time today.

ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus

Retrieved on: 
星期四, 一月 26, 2023
NYSE, ASX, SAN, ResMed, RMD, Management

SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the board, effective January 25, 2023.

Key Points: 
  • SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the board, effective January 25, 2023.
  • Mr. Farrell succeeds current chair Peter Farrell who will become chair emeritus and will remain an active board member.
  • Mick Farrell became ResMed’s CEO on March 1, 2013, and has served as a member of the company’s board of directors since assuming that role.
  • “I am honored to expand my role with ResMed as its next chair and to succeed my dad, Peter Farrell, whose vision, leadership, and guidance have helped ResMed become the largest outside-hospital, digital health company in the world,” said Mick Farrell.

Parks Associates Events Examine Expansion in Streaming and Connected Health as Consumers Embrace Connected Home Ecosystem

Retrieved on: 
星期四, 一月 19, 2023
CES, Comcast, Marketing, ResMed, OTT, Health, CT, ECG, Growth, Sinclair Broadcast Group, British Parking Association, OMRON, Mobile phone, Music, Adeia, DALLAS

DALLAS, Jan. 19, 2023 /PRNewswire/ -- Parks Associates today announced topics and speakers for two virtual sessions on January 26, Future of Video and Connected Health Summit, which will focus on the effects of expanding connectivity in key areas of consumer health and entertainment. The firm's ongoing quarterly surveys of 10,000 internet households show significant demand and growth in video streaming and connected health, and new product announcements from CES with continue to drive this growth in 2023.

Key Points: 
  • The firm's ongoing quarterly surveys of 10,000 internet households show significant demand and growth in video streaming and connected health, and new product announcements from CES with continue to drive this growth in 2023.
  • "These sessions address technology advancements and new services in healthcare and streaming," said Mindi Sue Sternblitz-Rubenstein , VP, Marketing, Parks Associates.
  • "The theme across consumer tech is the sheer volume of options to consider and willingness of consumers to subscribe to these emerging services."
  • These sessions, hosted January 26 starting at 11 am CT, feature visionary speaker Serhad Doken , CTO, Adeia, and include the following panelists:
    Scott Ehrlich , Chief Innovation Officer, Sinclair Broadcast Group

Sleep Apnea Devices Global Market Report 2023: Growing Popularity of Non-CPAP Devices for Sleep Apnea Treatment Boosts Sector

Retrieved on: 
星期四, 一月 19, 2023
Artificial intelligence, PAT, Ageing, Obstructive sleep apnea, Pulse oximetry, American Academy of Sleep Medicine, Sleep apnea, Pressure, Respiratory system, ResMed, OSA, Safety, CPAP, Actigraphy, AASM, Risk, Diagnosis, Patient, Prevalence, HST, Night, AHI, American Academy, PSG, Noise, Pharmaceutical industry, Medical device

DUBLIN, Jan. 19, 2023 /PRNewswire/ -- The "Sleep Apnea Devices Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 19, 2023 /PRNewswire/ -- The "Sleep Apnea Devices Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global sleep apnea devices market is expected to grow at a CAGR of 7.07% during 2022-2027.
  • The growing sleep apnea devices market is attributed to factors such as the high prevalence of sleep apnea, increasing potential risk factors, technological advancements in sleep apnea devices, and an increasingly aging population.
  • Itamar Medical, a leading player in the sleep apnea diagnostics market, offers WatchPat, the market-leading sleep apnea diagnostic device that uses this proprietary PAT technology.

Sleep Apnea Devices Global Market Report 2023: Emergence of Artificial Intelligence in Sleep Apnea Treatment Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
星期四, 一月 12, 2023
General Health, Health, Medical Devices, Artificial intelligence, PAT, Ageing, Obstructive sleep apnea, Pulse oximetry, American Academy of Sleep Medicine, Sleep apnea, Pressure, Respiratory system, ResMed, OSA, Safety, CPAP, Actigraphy, AASM, Risk, Diagnosis, Patient, Prevalence, HST, Night, AHI, American Academy, PSG, Noise, Pharmaceutical industry, Medical device

The "Sleep Apnea Devices Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sleep Apnea Devices Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global sleep apnea devices market is expected to grow at a CAGR of 7.07% during 2022-2027.
  • The growing sleep apnea devices market is attributed to factors such as the high prevalence of sleep apnea, increasing potential risk factors, technological advancements in sleep apnea devices, and an increasingly aging population.
  • Artificial intelligence (AI) will pave the way for screening and diagnosing OSA, reduce costly PSG deployment, and streamline the path to effective treatment in the sleep apnea devices market.

ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023

Retrieved on: 
星期四, 一月 12, 2023
Webcast, ResMed, Ridesharing company, Food delivery, Broadcasting

Please note: ResMed does not use outside phone lines to access the earnings call; the call is accessible via the above webcast link only.

Key Points: 
  • Please note: ResMed does not use outside phone lines to access the earnings call; the call is accessible via the above webcast link only.
  • A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast.
  • In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from January 26, 2023, until February 9, 2023, at:

ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference

Retrieved on: 
星期一, 一月 2, 2023
Conference, Westin St. Francis, NYSE, Pacific Standard, RMD, ResMed, SAN, ASX, Airline, Broadcasting

SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beginning at approximately 1:30 p.m. (Pacific Standard Time) at the Westin St. Francis in San Francisco, CA.

Key Points: 
  • SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beginning at approximately 1:30 p.m. (Pacific Standard Time) at the Westin St. Francis in San Francisco, CA.
  • More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com .
  • The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.

Razer Pushes the Boundaries of Gaming Innovation With Exciting Announcements at CES 2023

Retrieved on: 
星期四, 一月 5, 2023
Entertainment, Consumer Electronics, Technology, Mobile Entertainment, Electronic Games, Hardware, Antirrhinum, AAA, Enki, Skin, FPS, Multimedia, USD, Sony, Razer Blade Stealth Series, High dynamic range, ResMed, Razer, David Acord, HX, CES, Hygiene, Lighting, IR, Central Hall, Partnership, Booth, Verizon Communications, 3D, Kiyohime, Meta, GPD, Research, Android, Maintenance, Sale, ISO, Pan, Software, Ventilation, AMOLED, Light, Heart, VR, THX, Hypervigilance, HDR, RGB, Immersion, Video game, Video game console, Cassette tape, Tissue paper, Cryptocurrency, Camera

(CES 2023) – Razer™, the leading global lifestyle brand for gamers, ushers in its showcase at CES 2023 with all-new, innovative technologies for attendees to get exclusive first looks.

Key Points: 
  • (CES 2023) – Razer™, the leading global lifestyle brand for gamers, ushers in its showcase at CES 2023 with all-new, innovative technologies for attendees to get exclusive first looks.
  • Among groundbreaking concepts and product announcements, CES 2023 is the first opportunity for gamers and tech enthusiasts to get hands-on with the upcoming Razer Edge, the ultimate Android handheld gaming device.
  • With the Razer Blade 18, Razer takes an aggressive first step into the 18-inch laptop category, redefining the large-format laptop.
  • Razer also revealed two VR accessories for Meta Quest 2: The Razer Adjustable Head Strap System and the Razer Facial Interface.

Connected Care in North America - 2nd Edition: Market for Connected Medication Management is Gaining Traction

Retrieved on: 
星期二, 十二月 20, 2022
Patient, RPM, Obstructive sleep apnea, IOT, Wireless, ResMed, Mobile phone, Medical device

DUBLIN, Dec. 20, 2022 /PRNewswire/ -- The "Connected Care in North America - 2nd Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 20, 2022 /PRNewswire/ -- The "Connected Care in North America - 2nd Edition" report has been added to ResearchAndMarkets.com's offering.
  • The analyst forecasts that the number of cellular connections in the connected care market in North America will increase from 19.6 million in 2021 to more than 36.6 million in 2027.
  • This report has found that around 30.7 million people in North America were using connected care solutions at the end of 2022.
  • RPM is the largest segment of the connected care market with a total of 28.3 million users at the end of 2022.

Xealth Named to the 2022 CB Insights’ Digital Health 150 List

Retrieved on: 
星期三, 十二月 7, 2022
Aurora, Cleveland Clinic, CB Insights, R, ResMed, AR, Philips, FHIR, Froedtert Hospital, CB, Digital health, Providence St. Joseph Health, Cerner, Digital, Medical college, Digital technology, SVP, EHR, Research, History, Novartis, Workflow, Patient, UPMC, Video game, Retail, Mobile phone, Mosaic

New York, Dec. 07, 2022 (GLOBE NEWSWIRE) -- CB Insights today named Xealth , the leader in enabling digital health at scale, to its fourth-annual Digital Health 150 , showcasing the 150 most promising private digital health companies of 2022.

Key Points: 
  • New York, Dec. 07, 2022 (GLOBE NEWSWIRE) -- CB Insights today named Xealth , the leader in enabling digital health at scale, to its fourth-annual Digital Health 150 , showcasing the 150 most promising private digital health companies of 2022.
  • Through the Xealth Digital Care SMART on FHIR app, the platform brings digital health vendors, programs and tools into clinical and patient workflow.
  • Quick facts on the 2022 Digital Health 150:
    Equity funding and deals: Since 2017, this year's Digital Health 150 winners have raised around $5.6B in equity funding across 378 deals.
  • Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization.